WINDSOR, Conn., Oct. 4, 2021 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural fund. The fund will provide venture capital to health science and technology companies maturing beyond seed rounds.
The venture capital firm is building a proprietary platform to enable registered investment advisors to access venture capital investments for their retail clients. As a result, they needed a partner to provide proven independent fund administration for their new funds plus technology to support their retail client strategy. After evaluating multiple vendors, Mammoth Scientific chose SS&C’s private markets solution, including end-to-end fund administration with InvestorVision, SS&C’s investor reporting portal technology.
“We selected SS&C as a technology partner for the launch of our inaugural fund because of its extensive experience in private markets and its ability to deliver innovative solutions to power our vision,” said Jud Mackrill, Chief Experience Officer, Mammoth Scientific. “We wanted to democratize the early-stage alternative investment access and needed a bespoke solution to support the backbone of our operations. SS&C has the know-how and the breadth of technology to support us.”
“We are pleased to partner with Mammoth Scientific in the launch of their innovative inaugural VC fund,” said Bhagesh Malde, General Manager of SS&C GlobeOp Private Markets. “Mammoth [Scientific] is paving the way for accredited retail investors to access new alternative investment opportunities with their innovative platform. In addition, SS&C’s private markets offering enables start-ups, such as Mammoth [Scientific], to go to market and enable integrated operations quickly.”
About Mammoth Scientific
Mammoth Scientific is a venture capital company that specializes in health science and technology funds. Co-founders Dr. Jay Yadav, Tommy Martin, Kim Mackrill, Dr. Matthew McGirt and Jud Mackrill provide venture capital for health science and technology companies maturing beyond seed rounds. The Mammoth Scientific team includes seasoned physician entrepreneurs and highly successful operational managers, representing a twenty-year track record of creating and investing in multiple successful start-ups with large exits to major global companies (e.g., Abbott Laboratories, Boston Scientific, Johnson & Johnson) or to the public markets. To learn more about Mammoth Scientific and its Mammoth Health and Tech Fund, please visit Mammoth.vc.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 18,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.
Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.
MiRus, LLC is a portfolio company of Mammoth Scientific, LLC. Mammoth Scientific, Mammoth Private Capital Health and Tech Fund, the Mammoth logo, and the tagline “Invest Beyond the Ordinary” are trademarks of Mammoth Scientific, LLC and are protected by trademark laws of the United States and other countries. All other product and company names are trademarks or registered trademarks of their respective companies.
Venture fund management provided by Mammoth Scientific, LLC, an Exempt Reporting Adviser. Private capital platform services provided by The Securities Group, LLC dba Mammoth Research. Member FINRA/SIPC. Securities offered by Mammoth Scientific have not been registered under the Securities Act of 1933, as amended or the securities laws of any state or other jurisdictions in reliance upon exemptions from registration provided by the Securities Act and Regulation D Rule 506(c) and comparable exemptions.
Mammoth Scientific is an investment advisor to certain venture capital funds and files as an exempt reporting advisor, but that status does not imply a certain level of skill or training.